# Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides

> **NCT03085134** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 194 (actual)

## Conditions studied

- Cow's Milk Protein Allergy

## Interventions

- **OTHER:** Test infant formula with HMOs
- **OTHER:** Control infant formula without HMOs

## Key facts

- **NCT ID:** NCT03085134
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-22
- **Primary completion:** 2018-08-07
- **Final completion:** 2019-02-08
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03085134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03085134, "Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03085134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*